cognitive cybersecurity intelligence

News and Analysis

Search

Solvias Acquires Cergentis for Added Biologic and Cell & Gene Therapy Expertise

Solvias, an independent pharmaceutical testing and manufacturing companies, acquired Utrecht, Netherlands-based Cergentis. The acquisition was made to bolster Solvias’ platform of biologics and cell and gene therapy (CGT) testing solutions.
According to pharmaceutical market…

Source: www.genengnews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts